Janus Henderson Group
TARA icon

Janus Henderson Group’s Protara Therapeutics TARA Stock Holding History

Janus Henderson Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2M Buy
5,207,011
+65,395
+1% +$387K 0.01% 542
2025
Q4 		$27.4M Buy
5,141,616
+910,285
+22% +$5.06M 0.01% 534
2025
Q3 		$18.4M Buy
4,231,331
+128,711
+3% +$417K 0.01% 641
2025
Q2 		$12.5M Buy
4,102,620
+314,444
+8% +$1.08M 0.01% 672
2025
Q1 		$17.4M Buy
3,788,176
+1,516,344
+67% +$6.77M 0.01% 600
2024
Q4 		$11.9M Buy
+2,271,832
New +$7.34M 0.01% 691

Other funds holding TARA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Janus Henderson Group's TARA Position: Q1 2026 in Review

Janus Henderson Group increased its Protara Therapeutics (TARA) stake by 1.3% in Q1 2026, buying an estimated $387K and bringing the position to 5,207,011 shares worth $27.2M. The position accounts for 0.01% of the portfolio, ranked #542.

Janus Henderson Group first reported a position in TARA in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.4M in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Janus Henderson Group held 5,207,011 shares of Protara Therapeutics worth $27.2M as of Q1 2026.
  • Janus Henderson Group bought 65,395 Protara Therapeutics shares in Q1 2026, an estimated $387K.
  • Protara Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #542 holding.
  • Janus Henderson Group first reported a position in Protara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Janus Henderson Group's Protara Therapeutics position peaked at $27.4M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.